Orthofix Medical Inc. buy melinda
Start price
09.08.18
/
50%
€48.65
Target price
01.10.18
€55.74
Performance (%)
6.94%
End price
01.10.18
€52.03
Summary
This prediction ended on 01.10.18 with a price of €52.03. The BUY prediction by melinda finished with a performance of 6.94%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Orthofix Medical Inc. | 0.685% | 0.685% | -11.976% | -57.514% |
iShares Core DAX® | 1.665% | 0.362% | 17.556% | 15.301% |
iShares Nasdaq 100 | -0.475% | -3.195% | 26.812% | 36.536% |
iShares Nikkei 225® | 2.620% | 1.174% | 17.273% | 10.880% |
iShares S&P 500 | -0.091% | -1.597% | 24.739% | 36.919% |
Comments by melinda for this prediction
In the thread Orthofix Medical Inc. diskutieren
SecteurEquipement, fournitures et distribution médicale
Develops and markets surgical products to the spine and orthopedic markets
Orthofix Medical, Inc. engages in the research, development, and market of orthopedic solutions.
It operates through the following business segments: BioStim, Biologics, Extremity Fixation, and Spine Fixation.
The BioStim segment produces and sells devices for bone fusion enhancement in cervical and lumbar spine through the pulsed electromagnetic technology.
The Biologics segment includes regenerative products.
The Extremity Fixation segment manufactures and distributes orthopedic products for fracture repair, deformity correction, and bone reconstruction.
The Spine Fixation segment develops and sells implant products for spine surgeries.
The company was founded on October 19, 1987 and is headquartered in Lewisville, TX.
Orthofix Medical, Inc. engages in the research, development, and market of orthopedic solutions.
It operates through the following business segments: BioStim, Biologics, Extremity Fixation, and Spine Fixation.
The BioStim segment produces and sells devices for bone fusion enhancement in cervical and lumbar spine through the pulsed electromagnetic technology.
The Biologics segment includes regenerative products.
The Extremity Fixation segment manufactures and distributes orthopedic products for fracture repair, deformity correction, and bone reconstruction.
The Spine Fixation segment develops and sells implant products for spine surgeries.
The company was founded on October 19, 1987 and is headquartered in Lewisville, TX.
Nombre d'employés : 858 personnes.
(Vom Mitglied beendet)
Stopped prediction by melinda for Orthofix Medical Inc.
Orthofix Medical Inc.
Start price
Target price
Perf. (%)
€14.79
07.10.13
07.10.13
€17.00
07.04.14
07.04.14
62.66%
07.04.14
07.04.14